JPS628440B2 - - Google Patents

Info

Publication number
JPS628440B2
JPS628440B2 JP52049641A JP4964177A JPS628440B2 JP S628440 B2 JPS628440 B2 JP S628440B2 JP 52049641 A JP52049641 A JP 52049641A JP 4964177 A JP4964177 A JP 4964177A JP S628440 B2 JPS628440 B2 JP S628440B2
Authority
JP
Japan
Prior art keywords
weight
activity
protein
active fraction
phosphate buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52049641A
Other languages
English (en)
Japanese (ja)
Other versions
JPS53136592A (en
Inventor
Koichi Hosoda
Katsumi Nogimori
Isamu Takahashi
Shigeki Kurokawa
Tsutomu Nakamura
Motoyuki Yajima
Akira Ito
Akio Terajima
Taira Okamoto
Kazuo Murayama
Katsunori Kyo
Yoshinori Kanbayashi
Chikano Tomioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP4964177A priority Critical patent/JPS53136592A/ja
Publication of JPS53136592A publication Critical patent/JPS53136592A/ja
Publication of JPS628440B2 publication Critical patent/JPS628440B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
JP4964177A 1977-04-28 1977-04-28 Production of biologically active fraction Granted JPS53136592A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4964177A JPS53136592A (en) 1977-04-28 1977-04-28 Production of biologically active fraction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4964177A JPS53136592A (en) 1977-04-28 1977-04-28 Production of biologically active fraction

Publications (2)

Publication Number Publication Date
JPS53136592A JPS53136592A (en) 1978-11-29
JPS628440B2 true JPS628440B2 (pm) 1987-02-23

Family

ID=12836827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4964177A Granted JPS53136592A (en) 1977-04-28 1977-04-28 Production of biologically active fraction

Country Status (1)

Country Link
JP (1) JPS53136592A (pm)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5883629A (ja) * 1981-11-10 1983-05-19 Biseibutsu Kagaku Kenkyusho:Kk アジュバント
JPS59157029A (ja) * 1983-02-28 1984-09-06 Biseibutsu Kagaku Kenkyusho:Kk 動物用・住血原虫病不活化ワクチン

Also Published As

Publication number Publication date
JPS53136592A (en) 1978-11-29

Similar Documents

Publication Publication Date Title
JP6853331B2 (ja) セルライト処置用コラゲナーゼ
Yajima et al. Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats: purification and characterization
JP4851042B2 (ja) 糖尿病の治療方法
Pedrosa et al. Molecular cloning and expression of a functional dermonecrotic and haemolytic factor from Loxosceles laeta venom
US20210205446A1 (en) Conjugate vaccine targeting a disease-causing biological protein
JP2012116839A (ja) 膵臓障害の処置方法
BR112020020346A2 (pt) Neurotoxinas para uso na inibição de cgrp
AU2022203741B2 (en) Compositions and methods for treating diabetes, hypertension and hypercholesterolemia
JP2010502686A (ja) 末梢性神経障害の治療方法
US10058606B2 (en) Hepatitis B therapeutic vaccines
WO1981003124A1 (en) Polypeptide fraction from mussel for medical use
JPS6019733B2 (ja) 蛋白質性活性物質
JPS628440B2 (pm)
CN104961805A (zh) 一种蚕丝蛋白多肽及其制备和应用
Bout et al. Purification, immunochemical and biological characterization of malate dehydrogenase ofSchistosoma mansoni
Ismail et al. Preparation of a novel antivenom against Atractaspis and Walterinnesia venoms
Tarro et al. Human tumor antigens inducing in vivo delayed hypersensitivity and in vitro mitogenic activity
CN105693864A (zh) 一种三聚体trail蛋白及其应用
Davenport Plasma protein shedding by the canine oxyntic glandular mucosa induced by topical application of snake venoms and ethanol
JPH0147480B2 (pm)
CN108484760A (zh) 一种抗蓖麻毒素免疫球蛋白F（ab’）2及其制备方法
EP0673653B1 (en) Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it
Frank Treatment and prophylaxis of experimental renal hypertension in monkeys with renins and antirenins
JPS5946928B2 (ja) 糖尿病治療及び予防薬
JPS6210638B2 (pm)